drugset / Trial / NCT03762369
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of CKD-351.
Timeline
- Start
- 2018-12-07
- Primary completion
- 2022-02-28
- Completion
- 2022-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-351 | Unknown | — | — |
| Subject | D930 | Unknown | — | — |
| Comparator | Latanoprost | Small molecule | — | — |